230 related articles for article (PubMed ID: 26666308)
1. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
2. HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Gamba Cde O; Miranda FF; Alves MR; Rocha RM; de Barros AL; Cassali GD
PLoS One; 2016; 11(8):e0160419. PubMed ID: 27490467
[TBL] [Abstract][Full Text] [Related]
3. Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation.
Figuerêdo SH; Neto RSC; Ferreira E; Cassali GD; Estrela-Lima A; Damasceno KA
Res Vet Sci; 2021 Nov; 140():56-63. PubMed ID: 34399281
[TBL] [Abstract][Full Text] [Related]
4. Versican expression in canine carcinomas in benign mixed tumours: is there an association with clinical pathological factors, invasion and overall survival?
Damasceno KA; Bertagnolli AC; Estrela-Lima A; Ribeiro LG; Rabelo BS; Campos CB; Barros AL; Cassali GD
BMC Vet Res; 2012 Oct; 8():195. PubMed ID: 23082892
[TBL] [Abstract][Full Text] [Related]
5. Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2.
Bertagnolli AC; Ferreira E; Dias EJ; Cassali GD
Aust Vet J; 2011 Aug; 89(8):312-7. PubMed ID: 24635633
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
7. Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors.
Erdélyi I; van Asten AJ; van Dijk JE; Nederbragt H
Histochem Cell Biol; 2005 Aug; 124(2):139-49. PubMed ID: 16088379
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CD44 in canine melanocytic tumours.
Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of versican, in relation to chondroitin sulphate, in canine mammary tumours.
Erdélyi I; Nieskens DH; Van Dijk JE; Vass L; Nederbragt H
Histol Histopathol; 2003 Oct; 18(4):1067-80. PubMed ID: 12973676
[TBL] [Abstract][Full Text] [Related]
10. Versican expression in myoepithelial cells from carcinomas in canine mixed mammary tumors.
Damasceno KA; Bertagnolli AC; Estrela-Lima A; Rabelo BS; Campos LC; Ribeiro LG; Cassali GD
Vet J; 2014 Apr; 200(1):146-51. PubMed ID: 24582132
[TBL] [Abstract][Full Text] [Related]
11. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
[TBL] [Abstract][Full Text] [Related]
12. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
14. Expression of Oxytocin Receptors in Canine Mammary Tumours.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
16. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
17. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
[TBL] [Abstract][Full Text] [Related]
18. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
20. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
